Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Growth, Tolerance, and Functional Biomarkers in Healthy Infants Receiving Dietary Supplements: A Double-blind, Randomized Placebo-controlled Nutritional Study

NCT07630584 is registered in ClinicalTrials.gov with Société des Produits Nestlé (SPN) as lead sponsor.

NCT NCT07630584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07630584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Growth, Tolerance, and Functional Biomarkers in Healthy Infants Receiving Dietary Supplements: A Double-blind, Randomized Placebo-controlled Nutritional Study
Lead sponsor
Société des Produits Nestlé (SPN)
Phase
Not applicable
Overall status
Recruiting
Start date
August 11, 2026
Completion date
December 31, 2027
Enrollment
327 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy infants